No question, traders in the stock market knew there was going to be an appetite for shares of data visualization provider Tableau Software. But that hunger for business-tech IPO stocks is even deeper than Tableau guessed.
Shares of the Seattle-based company (NYSE:... Read more »
I was pretty slow about getting around to reading Thinking, Fast and Slow. The career-capping book by Princeton psychologist Daniel Kahneman, one of the founders of behavioral economics, spent months on all the bestseller lists back in 2011. I finally... Read more »
Few could accuse XBiotech CEO John Simard of failing to think big.
The Austin, TX-based startup he founded in 2005 is testing a novel biological drug candidate that is aiming to treat the persistent inflammation that makes cancer patients feel so... Read more »
[Clarification 5/17/13, 2:05 pm. See below.] Right on the same line with the original lede so you don’t waste space on a carriage return…Antibody drugs seemed to be the topic of the week for San Diego’s life sciences community.... Read more »
Wall Street’s hunger for business-tech companies is on display again with the initial public offering of Seattle-based Tableau Software.
Tableau, a provider of data-visualization software, begins trading today (NYSE: DATA) at $31 per share. That’s a higher price than... Read more »
All eyes in the biotech world will soon turn to the American Society of Clinical Oncology’s annual meeting in Chicago, but for now, the industry keeps humming along. This week’s news was highlighted by partnerships, product launches and big name hirings—and... Read more »
Science news often falls into the trap of becoming “infotainment” designed to generate ratings, and little else. As one essayist in The Guardian recently put it, “freaky copulation techniques in the animal kingdom,” heart-warming tales of miracle cures for kids, or... Read more »
The Boston area’s best-known startup hub is taking another big step in its national expansion plans.
The Cambridge Innovation Center, an all-in-one office space and services provider that houses some 500 companies near the MIT campus, is opening a branch... Read more »
AnaptysBio says today the U.S. government has asked the San Diego biotech to produce antibodies that counter the deadly effects of ricin and would not require refrigeration, so batches of anti-ricin antibodies could be stored at room temperatures.
Under a contract... Read more »